Policies on the use of dietary supplements in teaching hospitals [2]

American Journal of Health-System Pharmacy

Volumn 60, Issue 1, 2003, Pages 90-91

  Anderson, Philip O ^a   Morris, Providence D ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SYSTEM; DIET SUPPLEMENTATION; E-MAIL; HEALTH CARE POLICY; HEALTH SURVEY; HERBAL MEDICINE; HOSPITAL PATIENT; LETTER; PHARMACIST; PRIORITY JOURNAL; TERMINAL CARE; UNIVERSITY HOSPITAL;

EID: 0037223579     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.1.90     Document Type: Letter

References (6)

1. Feifer AH, Fleshner NE, Klotz L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol 2002; 168:150-4.
2. De Los Reyes GC, Koda RT. Determining hyperforin and hypericin content in eight brands of St. John's Wort. Am J Health-Syst Pharm. 2002; 59:545-7.
3. Nelson MH, Cobb SE, Shelton J. Variations in parthenolide content and daily dose of fever-few products. Am J Health-Syst Pharm. 2002; 59:1527-31.
4. Food and Drug Administration. Risk of Interactions With St. John's Wort and Indinavir and Other Medications. www.fda.gov/cder/drug/ advisory/stjohnwort.htm (accessed 2000 Feb 1).
5. Page RL II, Lawrence JD. Potentiation of warfarin by donq quai. Pharmacotherapy. 1999; 19:870-6.
6. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health-Syst Pharm. 2000; 1221-7.